Prediction of Microvascular Invasion of Hepatocellular Carcinoma Based on Contrast-Enhanced MR and 3D Convolutional Neural Networks.

Wu Zhou,Guangyi Wang,Hui Guo,Zaiyi Liu,Changhong Liang,Lijuan Zhang,Wanwei Jian,Xiaoping Cen

doi:10.3389/fonc.2021.588010

Abstract

Background and PurposeIt is extremely important to predict the microvascular invasion (MVI) of hepatocellular carcinoma (HCC) before surgery, which is a key predictor of recurrence and helps determine the treatment strategy before liver resection or liver transplantation. In this study, we demonstrate that a deep learning approach based on contrast-enhanced MR and 3D convolutional neural networks (CNN) can be applied to better predict MVI in HCC patients.Materials and MethodsThis retrospective study included 114 consecutive patients who were surgically resected from October 2012 to October 2018 with 117 histologically confirmed HCC. MR sequences including 3.0T/LAVA (liver acquisition with volume acceleration) and 3.0T/e-THRIVE (enhanced T1 high resolution isotropic volume excitation) were used in image acquisition of each patient. First, numerous 3D patches were separately extracted from the region of each lesion for data augmentation. Then, 3D CNN was utilized to extract the discriminant deep features of HCC from contrast-enhanced MR separately. Furthermore, loss function for deep supervision was designed to integrate deep features from multiple phases of contrast-enhanced MR. The dataset was divided into two parts, in which 77 HCCs were used as the training set, while the remaining 40 HCCs were used for independent testing. Receiver operating characteristic curve (ROC) analysis was adopted to assess the performance of MVI prediction. The output probability of the model was assessed by the independent student’s t-test or Mann-Whitney U test.ResultsThe mean AUC values of MVI prediction of HCC were 0.793 (p=0.001) in the pre-contrast phase, 0.855 (p=0.000) in arterial phase, and 0.817 (p=0.000) in the portal vein phase. Simple concatenation of deep features using 3D CNN derived from all the three phases improved the performance with the AUC value of 0.906 (p=0.000). By comparison, the proposed deep learning model with deep supervision loss function produced the best results with the AUC value of 0.926 (p=0.000).ConclusionA deep learning framework based on 3D CNN and deeply supervised net with contrast-enhanced MR could be effective for MVI prediction.

Highlights

Hepatocellular carcinoma (HCC) has become the fourth most common cause of cancerous death in the world [1]
We demonstrate that a deep learning approach based on contrast-enhanced MR and 3D convolutional neural networks (CNN) can be applied to better predict Microvascular invasion (MVI) in HCC patients
A deep learning framework based on 3D CNN and deeply supervised net with contrast-enhanced MR could be effective for MVI prediction

Summary

Introduction

Hepatocellular carcinoma (HCC) has become the fourth most common cause of cancerous death in the world [1]. Microvascular invasion (MVI) of HCC has been shown to be a key predictor of recurrence and poor prognosis. Preoperative knowledgement of MVI of HCC can be helpful in deciding treatment strategy and patient management [2]. The gold standard of MVI information is generally determined by the histopathological characteristics of HCC lesions [3, 4]. It is extremely important to predict the microvascular invasion (MVI) of hepatocellular carcinoma (HCC) before surgery, which is a key predictor of recurrence and helps determine the treatment strategy before liver resection or liver transplantation. We demonstrate that a deep learning approach based on contrast-enhanced MR and 3D convolutional neural networks (CNN) can be applied to better predict MVI in HCC patients

Methods

Results

Conclusion